ZimVie Stock (NASDAQ:ZIMV)
Previous Close
$13.17
52W Range
$8.95 - $22.40
50D Avg
$15.10
200D Avg
$16.87
Market Cap
$372.31M
Avg Vol (3M)
$179.41K
Beta
2.00
Div Yield
-
ZIMV Company Profile
ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.
ZIMV Performance
Peer Comparison
| Ticker | Company |
|---|---|
| APYX | Apyx Medical Corporation |
| OFIX | Orthofix Medical Inc. |
| SGHT | Sight Sciences, Inc. |
| LUNG | Pulmonx Corporation |
| SYK | Stryker Corporation |
| NPCE | NeuroPace, Inc. |
| SRDX | Surmodics, Inc. |
| STE | STERIS plc |
| KIDS | OrthoPediatrics Corp. |
| SIBN | SI-BONE, Inc. |
| AORT | Artivion, Inc. |
| SNN | Smith & Nephew plc |
| INGN | Inogen, Inc. |
| CVRX | CVRx, Inc. |
| CNMD | CONMED Corporation |